Get the Stockscreener App
10.70
4.49%
0.46
Clearpoint Neuro Inc stock is traded at $10.70, with a volume of 424.61K.
It is up +4.49% in the last 24 hours and down -4.63% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$10.24
Open:
$10.12
24h Volume:
424.61K
Relative Volume:
1.06
Market Cap:
$304.17M
Revenue:
$30.43M
Net Income/Loss:
$-18.15M
P/E Ratio:
-15.51
EPS:
-0.69
Net Cash Flow:
$-9.08M
1W Performance:
-7.36%
1M Performance:
-4.63%
6M Performance:
-36.00%
1Y Performance:
-5.89%
1-Day Range:
$10.12
$11.03
1-Week Range:
$10.06
$11.53
52-Week Range:
$9.76
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
10.70 | 318.96M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - MSN
Will ClearPoint Neuro Inc. stock benefit from AI tech trendsJuly 2025 Review & Fast Gain Stock Tips - Newser
Why ClearPoint Neuro Inc. stock attracts strong analyst attentionWeekly Risk Summary & Accurate Intraday Trade Tips - 선데이타임즈
What makes ClearPoint Neuro Inc. stock price move sharplyJuly 2025 Setups & Capital Protection Trade Alerts - thegnnews.com
Is ClearPoint Neuro Inc. stock entering bullish territoryJuly 2025 Outlook & Daily Entry Point Alerts - Newser
Pattern recognition hints at ClearPoint Neuro Inc. upsideEarnings Beat & Technical Buy Zone Confirmation - Newser
ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives - MSN
Resistance Break Could Fuel ClearPoint Neuro Inc. RallyPortfolio Value Summary & AI Optimized Trade Strategies - sundaytimes.kr
ClearPoint Neuro: Biopharma Momentum Continues To Build - Seeking Alpha
retail investors who own 49% along with institutions invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) saw increase in their holdings value last week - simplywall.st
ClearPoint Neuro Achieves Record Revenue in Q2 2025 - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2025 Earnings Call Transcript - Insider Monkey
Retail investors account for 49% of ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) ownership, while institutions account for 42% - Yahoo Finance
ClearPoint Neuro Reports Record Q2 Revenue Growth - MSN
ClearPoint Neuro (CLPT): Navigating Growth Amid Margin Pressures—Is Now the Time to Enter? - AInvest
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
ClearPoint Neuro 2025 Q2 Earnings Wider Losses Amid Revenue Growth - AInvest
ClearPoint Neuro's Q2 2025: Key Contradictions in MRI Utilization, GLP Compliance, and Revenue Growth - AInvest
Stock Market Insights - Seeking Alpha
ClearPoint Neuro Outlines Global Expansion Plans and Advances Cell and Gene Therapy Initiatives - AInvest
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts - Investing.com India
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
Clearpoint Neuro earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
ClearPoint Neuro Q2 Loss Widens, Revenue Rises - MarketScreener
ClearPoint Neuro: Balancing Near-Term Earnings Pressure with Long-Term R&D-Driven Growth - AInvest
ClearPoint Neuro Reports Q2 2025 Record Revenue of $9.2mln, 17% YoY Increase - AInvest
ClearPoint Neuro Reports Second Quarter 2025 Results - ACCESS Newswire
ClearPoint Neuro Hits Growth Milestone with Record Q2 Revenue, Lands Major $105M Financing Deal - Stock Titan
How moving averages guide ClearPoint Neuro Inc. tradingPrice Spike Prediction for Active Traders - Newser
Is ClearPoint Neuro Inc. stock reversal real or fakeFree Day Trading Signals With High Precision - Newser
Will ClearPoint Neuro Inc. stock go up soonFree Entry Plan for Oversold Reversal Stocks - Newser
Detecting support and resistance levels for ClearPoint Neuro Inc.Trade Safety Matrix for Conservative Traders - Newser
How high can ClearPoint Neuro Inc. stock price go in 2025Free Reversal Alert Based on RSI Indicator - Newser
Chart based analysis of ClearPoint Neuro Inc. trendsFree Risk Controlled Short Term Trade Plans - Newser
Live market analysis of ClearPoint Neuro Inc.Smart Trend Analysis With Buy Point Cues - Newser
Is it too late to sell ClearPoint Neuro Inc.Support and Resistance Zone Summary Chart - Newser
Leading vs lagging indicators on ClearPoint Neuro Inc. performancePredictable Income Summary for Long-Term Trades - Newser
Is ClearPoint Neuro Inc. meeting your algorithmic filter criteriaTechnical Setup Guide for Daily Watchlist - Newser
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
ClearPoint Neuro CLPT 2025Q2 Earnings Preview Upside Potential on Innovative Product Launch - AInvest
How ClearPoint Neuro Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Analyzing net buyer seller activity in ClearPoint Neuro Inc.Daily Market Momentum Summary and Strategy - Newser
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - ACCESS Newswire
Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan
How does ClearPoint Neuro Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What catalysts could drive ClearPoint Neuro Inc. stock higher in 2025Achieve unparalleled market performance - Jammu Links News
What are analysts’ price targets for ClearPoint Neuro Inc. in the next 12 monthsFree Trend-Following Techniques - Jammu Links News
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearpoint Neuro Inc Stock (CLPT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):